Marketing-authorisation holder
Bioton S.A.
2 medicines in 1 country, as authorisation holder and manufacturer.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Esomeprazol Bioton 20 mg harde maagsapresistente capsulesMaagsapresistente capsule, hard | Esomeprazole | Netherlands | Authorised | 2026 |
| Esomeprazol Bioton 40 mg harde maagsapresistente capsulesMaagsapresistente capsule, hard | Esomeprazole | Netherlands | Authorised | 2026 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 2 | 2 | 0 | CompaniesAll medicines |
Also in the registers of Brazil
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Drugs for acid-related disordersAlimentary tract and metabolism · ATC A02B
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- bioton
- bioton s a
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 2
- Countries
- 1
- Roles
- Authorisation holder and manufacturer